| Current and emerging direct oral anticoagulants: state-of-the-art G Lippi, R Gosselin, EJ Favaloro Seminars in thrombosis and hemostasis 45 (05), 490-501, 2019 | 76 | 2019 |
| Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis WJ Gibson, T Nafee, R Travis, M Yee, M Kerneis, M Ohman, CM Gibson Journal of thrombosis and thrombolysis, 1-9, 2019 | 69 | 2019 |
| Asymptomatic deep vein thrombosis is associated with an increased risk of death: insights from the APEX trial A Kalayci, CM Gibson, G Chi, MK Yee, S Korjian, S Datta, T Nafee, ... Thrombosis and haemostasis 118 (12), 2046-2052, 2018 | 65 | 2018 |
| Association of anemia with venous thromboembolism in acutely ill hospitalized patients: an APEX trial substudy G Chi, CM Gibson, AF Hernandez, RD Hull, SHA Kazmi, A Younes, ... The American journal of medicine 131 (8), 972. e1-972. e7, 2018 | 63 | 2018 |
| Machine learning to predict venous thrombosis in acutely ill medical patients T Nafee, CM Gibson, R Travis, MK Yee, M Kerneis, G Chi, F AlKhalfan, ... Research and practice in thrombosis and haemostasis 4 (2), 230-237, 2020 | 59 | 2020 |
| Most promising therapies in interventional cardiology M Kerneis, T Nafee, MK Yee, HA Kazmi, S Datta, M Zeitouni, MK Afzal, ... Current Cardiology Reports 21 (4), 26, 2019 | 37 | 2019 |
| A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic SA Brown, S Patel, D Rayan, S Zaharova, M Lin, T Nafee, B Sunkara, ... Cardio-oncology 7 (1), 2, 2021 | 36 | 2021 |
| Effect of procedure and coronary lesion characteristics on clinical outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the … M Kerneis, CM Gibson, G Chi, R Mehran, F AlKhalfan, U Talib, ... JACC: Cardiovascular Interventions 11 (7), 626-634, 2018 | 34 | 2018 |
| D-dimer levels and effect of rivaroxaban on those levels and outcomes in patients with acute coronary syndrome (an ATLAS ACS-TIMI 46 trial substudy) F AlKhalfan, M Kerneis, T Nafee, MK Yee, G Chi, A Plotnikov, ... The American Journal of Cardiology 122 (9), 1459-1464, 2018 | 30 | 2018 |
| Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients CM Gibson, T Nafee, MK Yee, G Chi, S Korjian, Y Daaboul, F AlKhalfan, ... American Heart Journal 198, 84-90, 2018 | 23 | 2018 |
| Anticoagulation in acute coronary syndrome-state of the art M Zeitouni, M Kerneis, T Nafee, JP Collet, J Silvain, G Montalescot Progress in Cardiovascular Diseases 60 (4-5), 508-513, 2018 | 23 | 2018 |
| Association of international normalized ratio stability and bleeding outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: Insights from … M Kerneis, MK Yee, R Mehran, T Nafee, C Bode, JL Halperin, ... Circulation: Cardiovascular Interventions 12 (2), e007124, 2019 | 19 | 2019 |
| Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors T Nafee, A Aslam, G Chi, S Pahlavani, D Nimri, AR Kuchkuntla, U Talib, ... Expert Review of Cardiovascular Therapy 15 (4), 237-245, 2017 | 19 | 2017 |
| Relation of white blood cell count to bleeding and ischemic events in patients with acute coronary syndrome (from the ATLAS ACS 2-TIMI 51 trial) F Alkhalfan, T Nafee, MK Yee, G Chi, A Kalayci, A Plotnikov, E Braunwald, ... The American Journal of Cardiology 125 (5), 661-669, 2020 | 15 | 2020 |
| Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial MK Yee, T Nafee, Y Daaboul, S Korjian, F AlKhalfan, M Kerneis, C Wiest, ... Journal of Thrombosis and Thrombolysis 45 (1), 1-8, 2018 | 15 | 2018 |
| State-of-art review: intravascular imaging in percutaneous coronary interventions T Nafee, A Shah, M Forsberg, J Zheng, J Ou Cardiology plus 8 (4), 227-246, 2023 | 14 | 2023 |
| Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention M Kerneis, U Talib, T Nafee, Y Daaboul, S Pahlavani, A Pitliya, ... Progress in Cardiovascular Diseases 60 (4-5), 524-530, 2018 | 14 | 2018 |
| Silent myocardial infarction: Listen to the evidence CM Gibson, T Nafee, M Kerneis Journal of the American College of Cardiology 71 (1), 9-11, 2018 | 13 | 2018 |
| When academic research organizations and clinical research organizations disagree: processes to minimize discrepancies prior to unblinding of randomized trials CM Gibson, SZ Goldhaber, AT Cohen, T Nafee, AF Hernandez, R Hull, ... American heart journal 189, 1-8, 2017 | 13 | 2017 |
| ASSERT trial–How to assess the safety and efficacy of a high frequency rTMS in postpartum depression? A multicenter, double blinded, randomized, placebo-controlled clinical trial T Andriotti, R Stavale, T Nafee, S Fakhry, MMA Mohamed, N Sofiyeva, ... Contemporary clinical trials communications 5, 86-91, 2017 | 13 | 2017 |
